CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational parainfluenza ...

Advance Best-In-Class Treatment Across CNS, Emergency Use Treatments, & Infectious Diseases & Secure Long-Term Funding in ...

The clearance return of 1.48 L/min was comparable to values obtained by fitting the intravenous and intranasal data separately. The bioavailability of fentanyl via the intranasal route was 89% ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

ILiAD Biotechnologies (ILiAD), a clinical-stage biotech company dedicated to the prevention and treatment of human disease ...

Before the nasal spray option, an EpiPen was the main way to reverse an anaphylactic reaction. Pharmacy data from last year ...

TAU’s groundbreaking project has received competitive research grants from the Israel Innovation Authority and Merck under ...

The global attenuated vaccines market is on track to achieve significant growth, with revenues projected to rise from USD ...

Experts say there's a right way and a wrong way to blow your nose when you're sick, and the wrong could make you worse.

A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution ...

It might feel good to blow your nose as hard as possible, but ear, nose and throat specialists say it can do more harm in the ...

Many people claim zinc supplements can prevent colds, shorten their duration or reduce the severity of symptoms. But the ...